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Background: Invasion of fibroblast-like synoviocytes (FLSs) is critical in the pathogenesis of rheumatoid arthritis
(RA). The metalloproteinases (MMPs) and activator of nuclear factor-kappa B (NF-κB) pathway play a critical role in
RA-FLS invasion induced by interleukin-1 beta (IL-1β) and tumour necrosis factor-alpha (TNF-α). The present study
aimed to explore the anti-invasive activity and mechanism of Celastrus orbiculatus extract (COE) on IL-1β and TNF-α
combination-stimulated human RA-FLSs.
Methods: We investigated the effect of COE on IL-1β and TNF-α combination-induced FLS invasion as well as MMP
expression and explored upstream signal transduction.
Results: COE suppressed IL-1β and TNF-α combination-stimulated FLSs invasion by inhibiting MMP-9 expression
and activity. Furthermore, our results revealed that COE inhibited the transcriptional activity of MMP-9 by
suppression of the binding activity of NF-κB in the MMP-9 promoter, and inhibited IκBα phosphorylation and
nuclear translocation of NF-κB.
Conclusions: COE inhibits IL-1β and TNF-α combination-induced FLSs invasion by suppressing NF-κB-mediated
MMP-9 expression.
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Rheumatoid arthritis (RA) is a complex chronic auto-
immune disease mainly affecting the joints, characterized
by abnormal synovial hyperplasia with marked pannus for-
mation and subsequent invasion and destruction of car-
tilage and bone [1,2]. Growing evidence suggests that
fibroblast-like synoviocytes (FLSs) in the lining layer can
attach to the cartilage and invade the extracellular matrix.
This aggressive invasive behaviour has an important role
in initiating and driving RA [3,4]. The migration of acti-
vated FLS is also partly responsible for spreading arthritis* Correspondence: guoqing1007@163.com; yanqingliu126@163.com
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unless otherwise stated.destruction to distant joints [5]. FLSs have inherent inva-
sive qualities not observed in other fibroblasts. The inva-
sion of FLSs in RA is considered to be as aggressive as
tumor cells [6]. Therefore, the regulation of cell migration
and invasion is a critical process throughout the develop-
ment of RA.
In RA, there is a link between inflammation and increased
bone damage. It is well established that pro-inflammatory cy-
tokines are key mediators of RA-FLS invasion and are in-
volved in the pathogenesis of RA [3]. Cytokines, such as
interleukin-1β (IL-1β), IL-6 and tumor necrosis factor (TNF-
α), can stimulate RA-FLS invasion, and increase the produc-
tion of matrix metalloproteinases (MMPs), which, in turn,
aggravate synovial inflammation resulting in joint destruction
[7-11]. FLSs play an essential role as effector cells in joint
destruction through the production of MMPs, mainly col-
lagenases and gelatinases [12]. The number of FLSs andhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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greatly increases in both the lining and sublining areas
of the RA synovium, and they produce various cytokines
and MMPs, infiltrate into neighbouring tissues, cause per-
sistent inflammation, and lead to joint destruction [13].
Cartilage destruction is caused by proteolysis induced by
MMPs that remodel the extracellular matrix. Further-
more, MMP degrading enzymes remove the extracellular
matrix (ECM), providing space for FLS to invade [14].
MMP-2 and MMP-9, also called collagenases, degrade
type IV collagen, gelatin and elastin, and are induced in
RA-FLS by pro-inflammatory cytokines, through the acti-
vation of transcription factors such as nuclear factor-κB
(NF-κB) and activator protein-1 (AP-1) [15].
Celastrus belongs to the family Celastraceae and is a
Chinese herb that has been used for centuries in folk
medicine for the treatment of various inflammatory dis-
eases [16]. Plant-derived herbal products are generally
less toxic and better tolerated than many conventional
drugs in the treatment of RA [17]. Many conventional
anti-arthritic drugs are effective in suppressing inflam-
mation but do not offer protection against bone damage
[18]. Celastrus orbiculatus extract (COE) is purified from
the Celastrus orbiculatus stem. We previously reported
that COE has a variety of anti-tumor effects [19]. Other
recent reports suggested that Celastrus extract has benefi-
cial anti-arthritic effects in an adjuvant-induced arthritis
(AIA) model [16,20,21]. Studies to define the therapeutic
mechanism of Celastrus extract in RA showed that it
inhibited inflammation-mediated bone remodelling in
an AIA model [22]. However, it’s utility for inhibiting
inflammation-induced RA-FLS invasion and the mecha-
nisms involved have not been examined. Therefore, this
study aimed to investigate the effects and mechanism of
COE on IL-1β and TNF-α combination-stimulated hu-
man RA-FLSs migration and invasion.Methods
Plant material and extraction
The stems of Celastrus orbiculatus (batch no. 070510)
were obtained from Guangzhou Zhixin Pharmaceutical
Co., Ltd. (Guangzhou, China) in 2007, and identified by
Professor Qiang Wang, Department of Chinese Materia
Medica Analysis, China Pharmaceutical University. A
voucher specimen (no. 20071300) was deposited in the
same department. Ethanol extract of Celastrus aculeatus
Merr. (COE) was prepared as previously described [19].
Briefly, stems of Celastrus were dried, powdered and
then extracted with 95% ethanol. The final ethyl acetate
extract was condensed and finally lyophilized into powder
(250 g) and stored at 4°C. The resultant micropowder was
diluted in dimethyl sulfoxide (DMSO) to the required
concentrations and filtered before use.Cell culture
RA-FLSs were isolated and cultured as described previ-
ously [23,24]. FLSs were grown in Dulbecco’s modified
Eagle’s medium/Nutrient Mixture F-12 (DMEM/F-12)
(Gibco, Grand Island, NY, USA) medium containing 10%
foetal bovine serum (FBS), supplemented with antibiotics
(100 mg/mL streptomycin and 100 U/mL penicillin ) in a
humidified incubator at 37°C under 5% CO2, 21% O2, and
75% N2 (Sanyo, Osaka, Japan). Cells used for experiments
were at the third to sixth passage. Isolated RA-FLSs were
identified by flow cytometry (FCM; BD Biosciences, San
Jose, CA, USA) as described previously.
Cell viability assay
All viability assays were based on the 3-(4, 5-dimethylthiazol-
2-yl)-2, 5-diphenyltetrazolium bromide (MTT) method.
Briefly, FLSs were seeded in a 96-well plate at a density of
1 × 104 cells/well. After treatment with various concentra-
tions of COE (5, 10, 20, 40 and 80 μg/ml) in triplicate for
20 h, cells were added to wells with 20 μl of MTT (5 mg/ml)
per well and incubated for an additional 4 h. Cells were
pelleted and lysed in 100 μl of DMSO and the absorbance
at 550 nm was measured using a microplate reader
(Thermo, Waltham, MA, USA).
Cell cycle determination
Cell cycle distribution was analysed by FCM. Briefly, FLSs
were plated at a density of 1 × 106 cells per 100-mm cul-
ture dish and treated with different concentrations (5, 10,
20 and 40 μg/ml) of COE for 24 h. Subsequently, the cells
were harvested, washed twice with phosphate buffer saline
(PBS), and fixed in 70% ethanol at 4°C for 1 h and centri-
fuged. Fixed cells were incubated with RNase (50 μg/ml)
for 30 min prior to staining nucleic acids with propidium
iodide (50 μg/ml) for 30 min at room temperature. The
sub G1 value in each group was analysed by FCM.
In vitro migration and invasion assay
Cell migration in vitro was determined using 6.5 mm
Transwell chambers with 8 μm pores (Corning, NY, USA).
COE treated-FLSs (1 × 105 cells) were plated in the upper
chambers in duplicate filters. In the outer wells, 900 μl
DMEM/30% FBS and IL-1β (10 ng/ml), TNF-α (10 ng/ml)
or IL-1β (10 ng/ml) and TNF-α (10 ng/ml) (R&D,
Minneapolis, MN, USA), were added to the lower cham-
ber. After a 48 h incubation period at 37°C and 5% CO2,
the cells were fixed with 2% paraformaldehyde in PBS
for 30 min at room temperature. After removal of para-
formaldehyde and subsequent washing with PBS, the
cells were stained with a crystal violet solution for
30 min at room temperature. The non-migrating cells
were removed from the upper surface by cotton swabs.
Cells that migrated through the membrane to the lower
surface were counted in five representative microscopic
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vasion ability was determined using Matrigel invasion
chambers (BD Biosciences, Tokyo, Japan) according to
the manufacturer’s instructions. The upper chambers
were freshly coated with Matrigel, and medium was
added to the lower chamber as described above. RA-
FLSs (5 × 104 cells) were suspended in medium contain-
ing 2% FBS and seeded into Matrigel pre-coated Trans-
well chambers. Cell invasion was allowed to occur for
48 h and the gel and cells on the top membrane surface
were removed with cotton swabs. Cells that had pene-
trated to the bottom were counted. All experiments
were performed in triplicate and repeated at least twice.Quantitative real-time polymerase chain reaction
(qRT-PCR)
Total RNA was extracted using Trizol according to the
manufacturer’s protocol. A SuperScript™ III Platinum®
SYBR® Green one-step qRT-PCR kit (Invitrogen, Carlsbad,
CA, USA) was used. Glyceraldehyde 3-phosphate de-
hydrogenase (GAPDH) was used as the internal control
for all analysis. The forward and reverse primers were de-
signed using Primer Express software (version 2.0-PE Ap-
plied Biosystems). The sequences of primers used were as
follows: MMP-1, 5′- ACT CTG GAG TAA TGT CAC
ACC T −3′ (F) and 5′- GTT GGT CCA CCT TTC ATC
TTC A −3′ (R); MMP-2, 5′- CCG TCG CCC ATC ATC
AAG TT −3′ (F) and 5′- CTG TCT GGG GCA GTC
CAA AG −3′ (R); MMP-3, 5′- AGT CTT CCA ATC CTA
CTG TTG CT −3′ (F) and 5′- TCC CCG TCA CCT
CCA ATC C-3′ (R); MMP-9, 5′- GGG ACG CAG ACA
TCG TCA TC −3′ (F) and 5′- TCG TCA TCG TCG AAA
TGG GC −3′ (R); GAPDH, 5′- ATC CCG CTA ACA
TCA AAT GG-3′ (F) and 5′- GTG GTT CAC ACC CAT
CAC AA −3′ (R). Primer specificity was assessed from
monophasic dissociation curves, and all had a similar effi-
ciency (data not shown). The threshold cycle (Ct) for the
endogenous control GAPDH mRNA and target signals
was determined, and relative RNA quantification was
calculated using the comparative 2−ΔΔCt method where
ΔΔCt = (CtTarget − CtGAPDH) − (CtControl − CtGAPDH). All
reactions were performed in duplicate.Enzyme-linked immunosorbent assay (ELISA)
The cell supernatants were collected for measurement of
secreted-MMP-1, 2, 3, and 9. Total and active MMP-9
protein was assayed according to the manufacturer’s
instructions for MMP-1, 2, 3, and 9 ELISA Systems
(GE Healthcare, Tokyo, Japan). MMP-1, 2, 3, and 9
activities were expressed as a change in fluorescence
intensity at an excitation wavelength of 490 nm/emission
of 520 nm.Western blot analysis
After experimental treatment, whole cell lysates from
FLSs were generated using a Total Protein Extraction
Kit (Millipore, Billerica, MA, USA) according to the man-
ufacturer’s instructions. Protein concentrations were deter-
mined using a Pierce BCA Protein Assay Kit (Thermo
Scientific, Tokyo, Japan). Equal amounts of protein
(30 μg) were separated by 10% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and trans-
ferred to ECL nitrocellulose membranes (Amersham Bio-
sciences, Piscataway, NJ, USA). After blocking with 5%
BSA for 2 h, blots were probed with primary antibodies at
4°C for 12 h, including primary antibodies against IκBα
(1:400), p65 (1:400), phospho-IκBα (p-IκBα) (1:500), p-p65
(1:500), MMP-2 (1:400), MMP-9 (1:400) and β-actin
(1:1000). All primary antibodies were from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Membranes were
then incubated with appropriate secondary antibodies for
2 h at room temperature. ECL reagent (GE Healthcare,
Tokyo, Japan) was used for protein detection. β-actin was
used as an internal control. The relative expression of each
protein was determined by densitometric analysis and
normalized to the control. Each blot shown is representa-
tive of at least three similar independent experiments.
Gelatin zymography
The enzymatic activities of MMP-2 and MMP-9 were
determined by gelatin zymography. Briefly, cells were
seeded and allowed to grow to confluence and then in-
cubated in serum-free medium for 24 h. The superna-
tants were collected 48 h after stimulation, mixed with
non-reducing sample buffer, and separated by 10% SDS-
PAGE containing 1% gelatin. After electrophoresis, gels
were renatured by washing in 2.5% Triton X-100 solu-
tion twice for 30 min to remove all SDS. The gels were
then incubated in 50 mM Tris–HCl (pH 7.5), 5 mM
CaCl2, and 1 μM ZnCl2 at 37°C overnight. Gels were
then stained with 0.25% Coomassie brilliant blue R-250
for 30 min and then destained in distilled water.
Transient transfection and luciferase reporter assay
To determine promoter activity, we used a dual-luciferase
reporter assay system (Promega, Madison, WI, USA).
MMP-9 promoter luciferase reporter plasmid and its
MMP-9 mutant NF-κB (mNF-κB) and MMP-9 mAP-1
were constructed using standard molecular biology tech-
niques as previously described [25]. RA-FLSs (1 × 105)
were seeded into 24-well plates and incubated at 37°C.
Cells at 70–80% confluence were co-transfected with re-
porter constructs and Renilla luciferase reporter vector
using Lipofectamine 2000 (Invitrogen, Carlsbad, CA,
USA) for 24 h according to the manufacturer’s protocol.
In the same experiment, we added an empty control plas-
mid to ensure that each transfection received the same
Li et al. BMC Complementary and Alternative Medicine 2014, 14:62 Page 4 of 12
http://www.biomedcentral.com/1472-6882/14/62amount of total DNA. The transfected cells were pre-
treated with COE for 1 h and then stimulated with 10 ng/ml
of IL-1β or/and TNF-α for 48 h, respectively. To assess
promoter activity, cells were collected and disrupted by
sonication in lysis buffer. After centrifugation, aliquots of
the supernatants were assayed according to the manufac-
turer’s protocol (Promega, Madison, WI, USA) using a
Luminometer (Turner BioSystems, Sunnyvale, CA, USA).
Relative luciferase activity (RLA) was normalized to Renilla
luciferase activity and expressed as the mean of three in-
dependent experiments.
Electrophoretic mobility shift assay (EMSA)
Cell nuclear lysates were harvested using a NucBuster™
Protein Extraction Kit (Novagen, Germany) according to
the manufacturer’s instructions. Nuclear extracts (10 μg)
were used to detect NF-κB translocation. Nuclei were re-
suspended in lysis buffer supplemented with 0.5 mM
DTT and 0.2 mM phenylmethylsulfonyl fluoride (PMSF).
The NF-κB consensus oligonucleotides (5′-AGT TGA
GGG GAC TTT CCC AGG C −3′) labelled with 32P by
T4 polynucleotide kinase (Promega, Madison, WI, USA)
were incubated with nuclear extracts in binding buffer atFigure 1 Effect of COE on IL-1β and TNF-α-induced FLSs migration an
concentrations of COE in serum containing medium for 24 h, and cell viab
control group. (B) FLSs were incubated with the indicated concentrations o
the sub-G1 phase was determined by FCM analysis. *P < 0.05 versus norma
were determined by cell migration and invasion assays. FLSs were pretreat
allowed to migrate with or without IL-1β (10 ng/ml), TNF-α (10 ng/ml), or I
of migrating and invasive cells in each chamber was plotted as the mean ± S
ANOVA. *P < 0.05, **P < 0.01 versus normal control group, ◆P < 0.05, ◆◆P < 0.0130°C for 30 min. The free DNA and DNA-protein mix-
tures were resolved using a 5% native polyacrylamide
gels in 0.5 × TBE buffer (0.4 M Tris, 0.45 M boric acid,
0.5 M EDTA, pH 8.0) by EMSA. Gels were dried and
subjected to autoradiography analysis.
Chromatin immunoprecipitation (ChIP) assay
To detect the in vivo association of nuclear proteins with
the human MMP-9 promoter, chromatin from FLSs was
fixed and immunoprecipitated using the ChIP assay kit
as recommended by the manufacturer (Upstate Biotech-
nology, NY, USA). Immune complexes were prepared
using anti-NF-κB p65 antibody. The supernatant of an
immunoprecipitation reaction carried out in the absence
of antibody was used as the total input DNA control.
After DNA purification, the presence of the selected
DNA sequence was assessed by PCR. PCR primers for
the MMP-9 promoter (373 bp including NF-κB cluster,
GenBank accession number AF538844) were as follows:
sense (5′-CAC TTC AAA GTG GTA AGA −3′), anti-
sense (5′-GAA AGT GAT GGA AGA CTC C −3′). PCR
products were resolved by 1.5% agarose gel and visualized
with UV light after being stained with ethidium bromide.d invasion. (A) FLSs were incubated with the indicated
ility was measured by MTT assay. *P < 0.05, **P < 0.01 versus normal
f COE for 24 h. Cells were harvested and the cell cycle distribution in
l control group. The migration (C) and invasion (D) abilities of FLSs
ed with the indicated concentrations of COE for 1 h. Then, FLSs were
L-1β (10 ng/ml) and TNF-α (10 ng/ml) for 48 h, respectively. The number
D in three independent experiments. The results were analysed by
versus IL-1β and TNF-α combination-treated group.
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All values are expressed as the mean ± SD, unless other-
wise stated. Results from different groups were analysed
by one-way analysis of variance (ANOVA) with Fisher’s
probable least-squares difference test or Student’s t-test.
Statistical analysis was performed using SAS 9.2 software
(SAS Institute Inc., NC, USA). Differences resulting in
probability (P) values less than 0.05 were considered sta-
tistically significant.
Results
Effect of COE on IL-1β and TNF-α-induced FLSs migration
and invasion
As shown in Figure 1(A), this experiment was under-
taken to examine the cytotoxic effect of COE on human
RA-FLSs. FLSs were treated with various concentrations
of COE in serum-containing medium for 24 h, and cell
viability was determined using the MTT assay. Treat-
ment with 5 to 20 μg/ml COE had no significant effect
on cell viability at 24 h. However, 40 μg/ml and 80 μg/ml
COE decreased cell viability by approximately 1 and 2.5-
fold, respectively, in comparison with the control group.
As shown in Figure 1(B), cell cycle analysis by FCM
showed that COE did not influence the cell cycle transi-
tion at low doses (5, 10 and 20 μg/ml), whereas high doses
(40 and 80 μg/ml) caused sub-G1 accumulation. There-
fore, COE had no significant cytotoxicity in FLSs at lowFigure 2 Effect of COE on mRNA expression of MMPs in IL-1β and TN
concentrations of COE for 1 h followed by IL-1β (10 ng/ml) and TNF-α (10
MMP-1(A), MMP-2 (B), MMP-3 (C) and MMP-9 (D) were measured by qRT-P
The histogram shows the mRNA levels from three independent experimen
versus IL-1β and TNF-α combination-treated group.doses. Based on data from preliminary studies, three dif-
ferent concentrations of COE (5, 10 and 20 μg/ml) were
chosen for the following experiments. Whether COE
could inhibit IL-1β and TNF-α-induced cell migration
and invasion was analysed using a Transwell chamber.
As shown in Figure 1(C) and (D), FLS migration was signifi-
cantly induced by IL-1β from a control level of 26 cells/field
to 91 cells/field (P < 0.05). This effect was similar to that
of TNF-α and their combination was more active, indu-
cing migration of 131 cells/field. Similarly, data obtained
from the invasion assay showed that combined IL-1β
and TNF-α increased cell invasion from a control level
of 6.5 cells/field to 49.2 cells/field (P < 0.01). However,
IL-1β and TNF-α combination-induced cell migration and
invasion were inhibited by COE in a dose-dependent
manner. These results suggest that non-toxic concentra-
tions of COE ranging from 5 to 20 μg/ml could inhibit
RA-FLSs migration and invasion induced by IL-1β and
TNF-α in vitro, indicating COE might provide benefit in
the treatment of RA by inhibiting inflammation-induced
FLSs invasion.
Effect of COE on mRNA expression of MMPs in IL-1β and
TNF-α-induced FLSs
As COE inhibited FLSs migration and invasion, this
prompted us to examine the effect of COE on MMP
gene expression. After stimulation of FLS with IL-1βF-α-induced FLSs. FLSs were incubated with the indicated
ng/ml) stimulation. After 48 h, the mRNA levels of endogenous
CR. GAPDH and β-actin were used as internal controls, respectively.
ts. *P < 0.05, **P < 0.01 versus normal control group, ◆P < 0.05, ◆◆P < 0.01
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TNF-α (10 ng/ml), MMP mRNA expression was deter-
mined. Figure 2 shows the mean levels for MMP-1, -2, -3
and -9 mRNA expression induced by two different cyto-
kines after 48 h of stimulation and pretreatment with
COE. mRNA expression of MMP-1 was similar with
MMP-2 after stimulation with IL-1β or TNF-α for 48 h,
although TNF-α induced a lower mRNA expression
of MMP-3 and MMP-9 compared with IL-1β. Our re-
sults showed that combined IL-1β and TNF-α induced
MMP-1, -2, -3 and -9 mRNA expression was higher
than IL-1β or TNF-α alone. There was a synergistic effect
in the IL-1β and TNF-α induced MMP-1, -2, -3 and -9
mRNA expression, whereas treatment with COE sup-
pressed IL-1β and TNF-α-induced MMP-9 expression in
a dose-dependent manner. Significant inhibition was seen
for MMP-9 mRNA expression after 48 h incubation withFigure 3 Effect of COE on MMP-2 and MMP-9 activity in IL-1β and TN
concentrations of COE for 1 h followed by IL-1β (10 ng/ml) and TNF-α (10
assayed for the amount and activity of secreted MMP-2 and MMP-9, by ELI
respectively. The histogram shows the ELISA and western blot results from
control group, ◆P < 0.05, ◆◆P < 0.01 versus IL-1β and TNF-α combination-treIL-1β and TNF-α (5 μg/ml or higher COE). However,
MMP-1, -2 and -3 mRNA expression was not affected by
COE pretreatment.
Effect of COE on MMP-2 and MMP-9 activity in IL-1β and
TNF-α-induced FLSs
Figure 3 shows the production of MMP-2 and MMP-9
by FLSs after stimulation with IL-1β (10 ng/ml), TNF-α
(10 ng/ml) or IL-1β (10 ng/ml) and TNF-α (10 ng/ml),
and also after pretreatment with COE (5 μg/ml, 10 μg/ml
or 20 μg/ml). As shown in Figure 3(C) and (D), there was
an obvious synergistic effect for the IL-1β and TNF-α in-
duced MMP-9 and MMP-2 protein expression, whereas
treatment with COE suppressed MMP-9 expression in a
dose-dependent manner. However, MMP-2 protein ex-
pression was not affected by COE treatment. We next ex-
amined the effect of COE on the secretion and proteolyticF-α-induced FLSs. FLSs were pretreated with the indicated
ng/ml) stimulation. After 48 h, the supernatants were collected and
SA (A and B), western blot (C and D) and gelatin zymography (E)
three independent experiments. *P < 0.05, **P < 0.01 versus normal
ated group.
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tioned medium. As shown in Figure 3(A-B) and (E), the
secretion and proteolytic activity of MMP-9 in FLSs were
induced when FLSs were cultured in serum-free medium
with 10 ng/ml of IL-1β or/and TNF-α for 48 h. The treat-
ment of FLSs with COE suppressed IL-1β and TNF-α-
induced MMP-9 secretion and activity in a dose-
dependent manner. These results indicate that COE se-
lectively inhibits IL-1β and TNF-α-induced MMP-9 ex-
pression at both the gene and protein levels, which
subsequently suppresses the enzymatic activity of MMP-9.
COE inhibits the transcriptional activity of MMP-9 by
suppression of NF-κB activity
The two principal pathways activated by IL-1 and TNF-α
are the NF-κB and AP-1 pathways [10,18], which induce
MMP-9 expression. The MMP-9 gene is regulated at the
transcriptional level by interactions of NF-κB and AP-1
with their binding sequences in the MMP-9 promoterFigure 4 COE inhibits the transcriptional activity of MMP-9 by suppre
MMP-9WT and Renilla luciferase reporter vector plasmids. The transfected c
followed by IL-1β (10 ng/ml) and TNF-α (10 ng/ml) stimulation for 48 h. Th
luciferase activity. Each value represents the mean ± SD of triplicate experim
with pGL2-MMP-9 mNF-κB (B), pGL2-MMP-9 mAP-1-U (C) and pGL2-MMP-9
luciferase activity and is expressed relative to the controls. *P < 0.05, **P < 0.
TNF-α combination-treated group.[26]. Because COE suppresses MMP-9 mRNA expression,
we tested which of these transcription factors might
regulate the MMP-9 gene in FLSs. FLSs were transiently
transfected with reporter genes that included the wild-
type MMP-9 promoter or a promoter with mutations in
the NF-κB site or in one or both AP-1 sites. As shown
in Figure 4, treatment with COE in the presence of IL-
1β and TNF-α decreased the transcriptional activity of
the reporter with the AP-1 mutation, but had no effect
on the reporter with NF-κB mutations, suggesting that
the target of COE is the NF-κB transcription factor. Fur-
thermore, the NF-κB inhibitor BAY, which blocks the
nuclear translocation of NF-κB, was used to examine
the involvement of NF-κB in IL-1β and TNF-α-induced
MMP-9 activation. FLSs were pretreated with BAY (5
and 10 μM) for 1 h and then stimulated with 10 ng/ml
of IL-1β and TNF-α for 48 h. qRT-PCR showed that
treatment of FLSs with BAY decreased IL-1β and TNF-
α-stimulated MMP-9 mRNA expression (Figure 5A),ssion of NF-κB activity. (A) RA-FLSs were transfected with pGL2-
ells were pretreated with the indicated concentrations of COE for 1 h,
e relative luciferase activity in the cell extract was normalized by Renilla
ents and is expressed relative to the control. FLSs were transfected
mAP-1-P (D). The relative luciferase activity is normalized to Renilla
01 versus normal control group, ◆P < 0.05, ◆◆P < 0.01 versus IL-1β and
Figure 5 NF-κB mediates IL-1β and TNF-α-induced MMP-9 expression. (A) FLSs were pretreated with BAY (5, 10 μM) for 1 h and then
stimulated with IL-1β (10 ng/ml) and TNF-α (10 ng/ml) for 48 h. MMP-9 mRNA expression in cells was analysed by qRT-PCR. GAPDH was used as
an internal control. The histogram shows the mRNA levels from three independent experiments. (B) and (C) FLSs were pretreated with BAY
(5, 10 μM) for 1 h and then stimulated with IL-1β (10 ng/ml) and TNF-α (10 ng/ml). After 48 h, conditioned media was collected and gelatin
zymography, western blotting or ELISA was performed. (D) FLSs were transfected with pGL2-MMP-9WT reporter plasmids and then cultured with
BAY (5, 10 μM) with or without IL-1β (10 ng/ml) and TNF-α (10 ng/ml) for 48 h. Luciferase activity in the cell extracts was determined. The data
are presented as mean ± SD of triplicate experiments. **P < 0.01 versus normal control group, ◆P < 0.05, ◆◆P < 0.01 versus IL-1β and TNF-α
combination-treated group.
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duced transcription of MMP-9. Culture media were
subjected to gelatin zymography and western blot ana-
lysis. As shown in Figure 5(B) and (C), BAY inhibited
IL-1β and TNF-α-induced MMP-9 protein expression
and activation. The effect of the NF-κB inhibitor on
MMP-9 promoter activity was investigated using FLSs
transiently transfected with a luciferase reporter gene
linked to the MMP-9 or NF-κB promoter sequence. As
shown in Figure 5(D), treatment of FLSs with the NF-κB
inhibitor clearly decreased the IL-1β and TNF-α-induced
luciferase activity.
COE inhibits the binding activity of NF-κB in the MMP-9
promoter
We examined the inhibitory effect of COE on the bind-
ing of NF-κB isolated from IL-1β and TNF-α-stimulated
FLSs to oligonucleotides that contained NF-κB binding
sites in the MMP-9 promoter using EMSA. As shown in
Figure 6(A), in vitro COE treatment suppressed IL-1β
and TNF-α-induced NF-κB binding to the MMP-9 pro-
moter on EMSA. Furthermore, we used ChIP to deter-
mine whether COE-suppressed NF-κB complexes couldbind with the MMP-9 promoter in vivo. Chromatin was
extracted and immunoprecipitated using anti-NF-κB
antibody, and the MMP-9 promoter region was ampli-
fied by PCR. As shown in Figure 6(B), in vivo binding of
NF-κB to the MMP-9 promoter increased in response to
IL-1β and TNF-α treatment, whereas NF-κB binding to
the MMP-9 promoter was significantly inhibited by
COE. These results further demonstrate that COE sup-
presses IL-1β-induced MMP-9 transcription through the
control of NF-κB. To characterize the molecules in-
volved in the inhibitory effect of COE, we next examined
whether COE regulated the NF-κB signalling pathway.
FLSs were pretreated with different concentrations of
COE for 1 h and stimulated with IL-1β and TNF-α for
48 h and then levels of the total or phosphorylated forms
of IκBα and p65 were measured by western blot. As
shown in Figure 6(C), IL-1β or/and TNF-α stimulation
induced significant phosphorylation of IκBα, and IκBα
degradation, but also increased phosphorylation of p65.
COE markedly inhibited the IL-1β and TNF-α-induced
phosphorylation of IκBα and p65 in a dose-dependent
manner. Increased IκBα levels correlated with a constant
decrease of phosphorylated IκBα in FLSs. These results
Figure 6 COE inhibits the binding activity of NF-κB in the MMP-9 promoter. FLSs were pretreated with the indicated amounts of COE for
1 h, and stimulated with IL-1β (10 ng/ml) and TNF-α (10 ng/ml) for 48 h. (A) The DNA binding activity of the nuclear extracts was examined by
EMSA using a probe containing the NF-κB motif in the MMP-9 promoter. NF-κB DNA binding activity was analysed by EMSA and shown is a
representative blot from three independent experiments. (B) The cross-linked chromatin was prepared and immunoprecipitated with antibody
and IgG to NF-κB p65 before amplification of the MMP-9 gene region containing the NF-κB site. Immunoprecipitates were analysed by PCR for
the presence of the MMP-9 gene promoter sequence using the primer pair described in material and methods. DNA purified from the sonicated
chromatin was directly analysed by PCR using the same primer set, which served as an input control (Input). Similar results were obtained in three
independent experiments. (C) FLSs were harvested and whole cell extracts were subjected to western blot analysis for the indicated proteins
(IκBα, p-IκBα, p65 and p-p65). A representative protein blot of three independent experiments is shown. β-actin served as a control. The histogram
shows the protein relative expression changes from three independent experiments. *P < 0.05, **P < 0.01 versus normal control group, ◆P < 0.05,
◆◆P < 0.01 versus IL-1β and TNF-α combination-treated group.
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NF-κB activation by suppressing IκBα phosphorylation
and the nuclear translocation of NF-κB in RA-FLSs.
Thus, COE inhibits NF-κB-dependent transcriptional ac-
tivation, resulting in the suppression of IL-1β and TNF-
α-induced MMP-9 expression in RA-FLSs.
Discussion
Celastrus has been utilized as a medicinal herb in trad-
itional Chinese medicine for the treatment of arthritis
for many decades [27]. Although several studies have
shown that Celastrus has anti-arthritic activities [21,27],
the precise mechanisms by which it can alleviate the
clinical symptoms of RA patients are not well defined. Itwas confirmed that human RA-FLSs express oncogenes
that are characteristic of actively dividing cells. Hence,
the growth and motility of FLSs from RA patients is un-
controlled, resulting in excessive proliferation and inva-
sion. Therefore, tumor therapy might be useful for RA
treatment. Our previous studies demonstrated that COE
has a variety of anti-tumor effects. Therefore, the present
study was undertaken to examine the possible therapeutic
mechanisms of Celastrus on RA-FLSs migration and in-
vasion in vitro. In this study, we assessed the effect of
COE on IL-1β and TNF-α-induced RA-FLSs motility.
Our results clearly showed that treatment of RA-FLSs
with COE suppressed IL-1β and TNF-α-induced cell
migration and invasion, and revealed that COE inhibited
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the binding activity of NF-κB in the MMP-9 promoter,
and inhibited IκBα phosphorylation and NF-κB nuclear
translocation.
MMP-2 and MMP-9 are important ECM-degrading
enzymes, and overexpression of MMPs is important for
the invasiveness of RA-FLSs [28,29]. IL-1β and TNF-α
are important pro-inflammatory cytokines in the RA-
FLS microenvironment that stimulate FLS to secrete
MMPs. This induction is regulated at the transcriptional
and translational levels [14]. In the present study, IL-1β
and TNF-α induced MMP-1, -2, -3 and -9 expression with
an obvious synergistic effect. Furthermore, increased
MMP-9 expression and secretion was inhibited by COE.
These results therefore indicate that the inhibition of IL-
1β and TNF-α-induced FLSs invasion by COE occurs pri-
marily by inhibiting MMP-9 expression and activity. The
two principal pathways activated by IL-1β and TNF-α are
the NF-κB and mitogen-activated protein kinase (MAPK)
pathways, and the roles of both in the pathogenesis of de-
structive arthritis have been reported [9,10]. The MMP-9
promoter region contains a cis-regulatory element, includ-
ing one NF-κB, two AP-1 and one stimulatory protein-1
(SP-1) binding sites [30]. To identify the mechanism of
COE-induced inhibition of MMP-9 expression, we ex-
amined MMP-9 promoter activity using wild type and
mutant reporter plasmids. COE suppressed MMP-9-
induction by repressing transcription activation of the
MMP-9 promoter. Mutational analysis of the promoter
revealed that the major target of COE was NF-κB, which
was further confirmed by the use of reporter plasmids
containing synthetic elements specific for the transcrip-
tion factors.Figure 7 Schematic diagram. COE inhibits the IL-1β and TNF-α-induced m
TNF-α-induced phosphorylation and degradation of IκBα, which inhibits th
NF-κB, and, thus, decreases MMP-9 expression and the subsequent migratioNext, we investigated the functional significance of
NF-κB transactivation of MMP-9 activation in RA-FLSs.
Results from in vitro EMSA and in vivo ChIP assays
showed that COE suppressed IL-1β and TNF-α-induced
NF-κB binding to the MMP-9 promoter. Given that NF-
κB regulates transcriptional activation of multiple inflam-
matory cytokines, we expected that COE might target NF-
κB to suppress MMP-9 transcription by IL-1β and TNF-α.
NF-κB is sequestered in the cytoplasm by binding to IκB
family molecules and is activated by IκBα phosphorylation
whose subsequent degradation in the proteasome allows
the NF-κB subunits, p65 and p50, to enter the nucleus
and activate target genes [31]. To address whether COE
modulated the NF-κB signalling pathway, we attempted to
analyze the presence of native and phosphorylated forms
of IκBα in the absence or presence of COE. We showed
that IL-1β and TNF-α induced phosphorylation of IκBα
and triggered degradation of IκBα in RA-FLSs with a syn-
ergistic effect and that IL-1β and TNF-α inhibited the ef-
fect in a dose-dependent manner. Phosphorylation of p65
by IL-1β is associated with nuclear translocation and
transactivation potential [32]. We also showed that COE
inhibited the IL-1β and TNF-α-induced phosphorylation
of p65.
The above findings collectively demonstrate that COE
inhibits IL-1β and TNF-α-induced NF-κB activity via the
IκB pathway, inhibits MMP-9 expression and proteolytic
activity, which in turn, suppresses the migration and in-
vasion ability of FLSs (Figure 7). Several conventional
drugs are available for treating RA, however, the effect
of different therapeutic agents on inflammation and
bone damage may be separate. Certain drugs can sup-
press inflammation effectively, but fail to protect againstigration and invasion signal pathway in FLSs. COE blocks IL-1β and
e nuclear translocation of p65. This further suppresses the activation of
n and invasion of FLSs.
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erosion can be halted, but inflammation may continue
unabated. In this context, our results show that COE
may control both inflammation and bone damage in RA
pathogenesis.
Conclusion
Taken together, the present study indicates that COE in-
hibits IL-1β and TNF-α-induced RA-FLSs migration and
invasion by suppressing NF-κB-mediated MMP-9 ex-
pression. Although further work is needed to clarify the
active ingredients and complicated mechanism of COE-
induced anti-invasion effect on FLSs, we suggest that
COE is a promising agent for the concurrent treatment
of inflammation and bone damage associated with arth-
ritis. Furthermore, natural products should be further
tested in clinical studies for their use as adjuncts to con-
ventional drugs for the treatment of RA.
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